| Literature DB >> 28935925 |
Elisa Wirthgen1,2, Martin Kunze1, Sébastien Goumon3, Christina Walz1, Christine Höflich2, Marion Spitschak1, Julia Brenmoehl1, Ellen Kanitz4, Margret Tuchscherer4, Winfried Otten4, Ulrike Gimsa4, Peter Schön4, Christian Manteuffel4, Armin Tuchscherer5, Ralf Pfuhl6, Cornelia C Metges7, Bernd Stabenow8, Sandra Erdmann9, Kathleen Schluricke1, Luigi Faucitano10, Andreas Hoeflich11.
Abstract
The acceptance of animal products is increasingly associated with standardized animal welfare, which relates to appropriate animal husbandry from birth to slaughter. In particular, shipment to the slaughterhouse is considered as a critical process exposing the animals to a number of, in part severe, stressors. New biomarkers may be useful for the assessment of animal welfare. The IGF-system has been assessed in a commercial pig transport in conjunction with established markers of stress response. Furthermore, the effect of repeated restraint as an experimental model for repeated acute stress was investigated. During shipment from farm to slaughterhouse, plasma concentrations of IGFBP-3 and IGFBP-2 were significantly reduced (p < 0.01). After shipment, the plasma concentrations of IGFBP-5, glucocorticoids and IL-2 increased but decreased after lairage (p < 0.05) whereas IGF-1 decreased after shipment (p < 0.01). Repeated acute stress increased concentrations of IGFBP-3 and IGF-1 in exsanguination blood (p < 0.05). Differential IGF- signatures can indicate altered endocrine or metabolic control and thus contain complex animal-related information. The somatotropic axis may be of particular interest when established biomarkers such as cortisol, glucose, or lactate cannot be used for the assessment of animal stress or welfare.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28935925 PMCID: PMC5608691 DOI: 10.1038/s41598-017-11521-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1IGF-system at different sampling times of transportation procedure: IGFBP-profile (A), IGFBP-3 ((B); n = 31), IGFBP-2 ((C); n = 31), IGFBP-5 ((D); n = 31), IGF-1 ((E); n = 13) and IGF-2 ((F); n = 13). Quantitative data are presented as LS-means+ SE. rh: recombinant human. *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.1.
Figure 2The total amount of IGFBPs as marker for IGF-binding capacity ((A); n = 31) and the ratio of IGF-1/total IGFBPs as indicator for IGF-1 bioavailability ((B), n = 13) during different stations of transport. Data are presented as LS-means+ SE. *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 3Effect of transport duration on plasma IGFBP-2 ((A); n = 240) and cortisol ((B); n = 90). IGFBP-2 was analyzed using quantitative Western ligand blot. Cortisol was analyzed using LC-MS/MS. Data are presented as LS-means+ SE. *p < 0.5, **p < 0.01, ***p < 0.001.
Figure 4Stress and inflammation associated parameters at different sampling times of commercial transportation procedure: Plasma concentrations of cortisol (A), corticosterone (B), adrenaline (C) and noradrenaline (D), IL-2 (E), SAA (F) and albumin (G). Cortisol, IL-2 and SAA were analyzed with ELISA. Corticosterone was analyzed using LC-MS/MS. Adrenaline and noradrenaline were analyzed using HPLC. Albumin was analyzed using an enzymatic spectrophotometric assay. All Data are presented as LS-means+ SE. Cortisol, adrenaline, noradrenaline, SAA: n = 31 per sampling time. Corticosterone, IL-2, albumin: n = 13 per sampling time. #p < 0.1, *p < 0.05, ** p < 0.01, ***p < 0.001.
Figure 5Stress vocalization and evaluation of lesions at different events of pig transport. (A) Stress vocalization, presented as LS-means + SE of every event, respectively. (B) Exemplary data of stress vocalization during different events of trial 2. (C) The number of lesions measured in home pen and after transport, presented as LS-means + SE. (D) Percentage of animals per category of transport-induced increase of lesion score. The stress vocalization was analysed using STREMODO and includes all animals in the range of sound recorder. Lesions: n = 65. *p < 0.05, **p < 0.01, ***p < 0.001.
Effect of repeated blood sampling (three times) in the pre-slaughter period on plasma parameters and meat quality in exsanguination blood, collected directly after slaughter.
| Parameters | Treatment group | n | Control group | n | p-value |
|---|---|---|---|---|---|
|
| |||||
| IGFBP-3 (ng/ml) | 2855.21 ± 165.38 | 31 | 2362.57 ± 152.13 | 34 | 0.0323 |
| IGFBP-2 (ng/ml) | 904.46 ± 57.96 | 31 | 998.26 ± 53.31 | 34 | 0.2384 |
| IGFBP-5 (ng/ml) | 653.20 ± 86.31 | 31 | 489.71 ± 80.41 | 34 | 0.1723 |
| IGF-1 (ng/ml) | 157.44 ± 17.31 | 13 | 108.07 ± 15.74 | 14 | 0.0476 |
| IGF-2 (ng/ml) | 82.82 ± 8.63 | 13 | 82.60 ± 7.66 | 14 | 0.9845 |
| Total IGFBPs (ng/ml) | 4098.24 ± 232.44 | 31 | 3725.65 ± 289.55 | 34 | 0.2180 |
| IGF-1/total IGFBPs | 0.04 ± 0.004 | 13 | 0.03 ± 0.004 | 14 | 0.0616 |
| IGF-1/IGFBP-3 | 0.06 ± 0.01 | 13 | 0.05 ± 0.01 | 14 | 0.1301 |
| IGF-1/IGFBP-2 | 0.19 ± 0.02 | 13 | 0.13 ± 0.02 | 14 | 0.0519 |
| IGF-1/IGFBP-5 | 0.21 ± 0.05 | 13 | 0.16 ± 0.03 | 14 | 0.3608 |
| IGFBP-3/IGFBP-2 | 3.44 ± 0.29 | 31 | 2.60 ± 0.27 | 34 | 0.0392 |
| Glucose (mg/dl) | 157.11 ± 10.51 | 13 | 153 ± 9.54 | 14 | 0.8054 |
| Albumin (g/dl) | 33.96 ± 1.21 | 13 | 33.07 ± 1.10 | 14 | 0.5873 |
| IL-2 (ng/ml) | 21.52 ± 4.98 | 13 | 30.73 ± 5.65 | 14 | 0.2435 |
| Cortisol (ng/ml) | 50.49 ± 5.03 | 31 | 50.73 ± 4.67 | 34 | 0.9720 |
| Corticosterone (ng/ml) | 2.51 ± 0.60 | 13 | 4.47 ± 0.57 | 14 | 0.0273 |
| Lactate (mmol/l) | 5.90 ± 0.66 | 31 | 8.57 ± 0.61 | 34 | 0.0043 |
| Cholesterol (g/l) | 1.26 ± 0.05 | 13 | 1.26 ± 0.04 | 14 | 0.9240 |
| Triglycerides (g/l) | 0.57 ± 0.05 | 13 | 0.45 ± 0.05 | 14 | 0.0819 |
| Serum Amyloid A (µg/ml) | 17.42 ± 4.03 | 31 | 7.60 ± 4.78 | 34 | 0.1694 |
| Adrenaline (ng/ml) | 189.48 ± 14.70 | 31 | 163.26 ± 13.52 | 34 | 0.1945 |
| Noradrenaline (ng/ml) | 511.62 ± 33.82 | 31 | 409.48 ± 31.11 | 34 | 0.0301 |
|
| |||||
| Hot carcass weight (kg) | 93.05 ± 1.16 | 31 | 92.93 ± 1.08 | 34 | 0.9352 |
| Lean content (kg) | 57.86 ± 0.48 | 31 | 58.50 ± 0.46 | 34 | 0.3388 |
| Lean yield (%) | 62.49 ± 0.93 | 31 | 63.29 ± 0.89 | 34 | 0.5346 |
|
| |||||
| pH1 | 6.42 ± 0.03 | 31 | 6.50 ± 0.03 | 34 | 0.0713 |
| pH2 | 5.48 ± 0.03 | 31 | 5.49 ± 0.03 | 34 | 0.7362 |
| Drip loss (%) | 2.30 ± 0.14 | 31 | 2.40 ± 0.13 | 34 | 0.6061 |
Data are presented as LS-means ± SE and p-value is given for the pairwise comparison between the treatment group (with repeated blood sampling by snaring) and the control group (without repeated blood sampling) using Tukey-Kramer procedure.
Rank correlation of metabolic and stress related parameters after Spearman.
| Parameter 1 | Parameter 2 | Sample size | p-value | RSpearman | Correlation |
|---|---|---|---|---|---|
| IGFBP-3 | IGFBP-2 | 156 | <0.001 | 0.40 | moderate |
| IGFBP-3 | total IGFBPs | 156 | <0.001 | 0.94 | high |
| IGFBP-3 | IGF-1 | 57 | <0.001 | 0.45 | moderate |
| IGFBP-3 | Glucose | 67 | <0.001 | −0.48 | moderate |
| IGFBP-3 | Lactate | 156 | <0.01 | −0.24 | moderate |
| IGFBP-3 | IGFBP-3/-2 ratio | 156 | <0.001 | 0.56 | distinct |
| IGFBP-2 | total IGFBPs | 156 | <0.001 | 0.55 | distinct |
| IGFBP-2 | SAA | 156 | <0.05 | −0.16 | low |
| IGFBP-2 | IGFBP-3/-2 ratio | 156 | <0.001 | −0.46 | moderate |
| IGFBP-5 | total IGFBPs | 130 | <0.001 | 0.32 | moderate |
| IGFBP-5 | Cholesterol | 58 | <0.05 | −0.33 | moderate |
| IGFBP-5 | Cortisol | 130 | <0.001 | 0.31 | moderate |
| total IGFBP | TG | 65 | <0.01 | −0.37 | moderate |
| total IGFBP | Glucose | 67 | <0.001 | −0.44 | moderate |
| total IGFBP | Lactate | 156 | <0.01 | −0.22 | moderate |
| total IGFBP | IGFBP-3/-2 ratio | 156 | <0.001 | 0.36 | moderate |
| IGF-1 | total IGFBPs | 57 | <0.01 | 0.41 | moderate |
| IGF-1 | Cortisol | 57 | <0.001 | −0.31 | moderate |
| IGF-1 | Corticosterone | 57 | <0.05 | −0.32 | moderate |
| IGF-1 | IGF-2 | 57 | <0.001 | 0.38 | moderate |
| IGF-1 | Glucose | 57 | <0.001 | −0.45 | moderate |
| IGF-1 | IGFBP-3/-2 ratio | 57 | <0.001 | 0.49 | moderate |
| IGF-1 | Lactate | 57 | <0.001 | −0.43 | moderate |
| IGF-1 | Albumin | 57 | <0.05 | −0.31 | moderate |
| IGF-2 | Lactate | 57 | <0.05 | −0.27 | moderate |
| Albumin | Cortisol | 57 | <0.05 | 0.29 | moderate |
| Albumin | Corticosterone | 57 | <0.001 | 0.57 | distinct |
| Albumin | Lactate | 66 | <0.05 | 0.31 | moderate |
| Albumin | IGFBP-3/-2 ratio | 66 | <0.05 | −0.28 | moderate |
| Glucose | TG | 65 | <0.001 | 0.60 | distinct |
| Glucose | Lactate | 67 | <0.001 | 0.59 | distinct |
| Glucose | IGFBP-3/-2 ratio | 67 | <0.001 | −0.47 | moderate |
| Cortisol | Corticosterone | 65 | <0.001 | 0.67 | distinct |
| Cortisol | Lactate | 155 | <0.01 | 0.25 | moderate |
| Corticosterone | IGFBP-3/-2 ratio | 65 | <0.01 | −0.32 | moderate |
| Lactate | IGFBP-3/-2 ratio | 156 | <0.01 | −0.21 | moderate |
Only correlations with a p-value < 0.05 are presented. The Spearman correlation coefficient (RSpearman) was classified as low (0,0 ≤ R ≤ 0,2), moderate (0,2 < R ≤ 0,5), distinct (0,5 < R ≤ 0,8) and high (0,8 < R ≤ 1,0).
Conditional biomarker potential of physiological parameters.
| Factor | Effect on physiological parameters/biomarker potential |
|---|---|
| Short-term fasting | no effect on IGF-compounds assessed |
| Time of the day | IGFBP-3 ↓ |
| Shipment versus basal | Corticoids ↑ |
| IGF-1 ↓, IGFBP-5 ↑ | |
| Lairage versus shipment | Corticoids ↓, IL-2 ↓ |
| IGFBP-5 ↓ | |
| Slaughter versus lairage | Catecholamines ↑, Glucose ↑, Triglycerides ↑, Lactate ↑, Cholesterol ↑ |
| Slaughter versus basal | Catecholamines ↑, Glucose ↑, Lactate ↑, Triglycerides ↑ |
| IGFBP-2↓ | |
| Restraint stress | Corticosterone ↓, Lactate ↓, |
| IGF-I ↑, IGFBP-3 ↑, IGFBP-3/IGFBP-2 ↑ | |
| Transport duration | IGFBP-2↓ |